Page last updated: 2024-08-23

epirubicin and Diabetes Mellitus, Type 2

epirubicin has been researched along with Diabetes Mellitus, Type 2 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geng, C; Li, X; Qi, X; Sun, F1
Geng, C; Shi, J; Sun, F1
Böhm, S; Brändle, M; Gillessen, S; Hess, D1
Chang, WL; Chao, TC; Gau, JP; Liu, YC1

Trials

2 trial(s) available for epirubicin and Diabetes Mellitus, Type 2

ArticleYear
Dexrazoxane protects breast cancer patients with diabetes from chemotherapy-induced cardiotoxicity.
    The American journal of the medical sciences, 2015, Volume: 349, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiotonic Agents; Cardiotoxicity; Cyclophosphamide; Dexrazoxane; Diabetes Mellitus, Type 2; Drug Monitoring; Epirubicin; Female; Heart Function Tests; Humans; Middle Aged; Treatment Outcome

2015
Dexrazoxane improves cardiac autonomic function in epirubicin-treated breast cancer patients with type 2 diabetes.
    Medicine, 2016, Volume: 95, Issue:44

    Topics: Antineoplastic Agents; Autonomic Nervous System; Breast Neoplasms; Dexrazoxane; Diabetes Mellitus, Type 2; Epirubicin; Female; Heart; Humans; Middle Aged; Prospective Studies

2016

Other Studies

2 other study(ies) available for epirubicin and Diabetes Mellitus, Type 2

ArticleYear
Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib.
    Diabetes care, 2010, Volume: 33, Issue:6

    Topics: Aged; Antibiotics, Antineoplastic; Blood Glucose; Diabetes Mellitus, Type 2; Epirubicin; Humans; Hypoglycemic Agents; Indazoles; Male; Prostatic Neoplasms; Pyrimidines; Sulfonamides

2010
Primary bone lymphoma of the shoulder.
    British journal of haematology, 2012, Volume: 158, Issue:6

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Diabetes Mellitus, Type 2; Epirubicin; Female; Humans; Humerus; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Middle Aged; Osteolysis; Prednisolone; Radiography; Rituximab; Vincristine

2012